CGEN Competitors & Alternatives
Compare Compugen with similar stocks in the same industry
Biotechnology
CGEN
Main Stock$2.71
Tradestie Score
56
Market Cap
$149.66M
P/E Ratio
7.0
Revenue Growth
44.8%
Analyst Upside
+115.3%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$29.06
|
$293.03M | - | 56 | Compare |
|
CERS
Cerus Corp
|
$2.72
|
$291.38M | - | 40 | Compare |
|
OMER
Omeros Corporation
|
$15.06
|
$281.75M | - | 61 | Compare |
|
DBVT
DBV Technologies S.A.
|
$19.87
|
$275.54M | - | 54 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.15
|
$275.13M | - | 51 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$13.85
|
$269.08M | - | 48 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.87
|
$258.18M | - | 50 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
TRDA
Entrada Therapeutics, Inc. Common Stock
|
$14.50
|
$223.66M | - | 59 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$4.93
|
$211.22M | - | 57 | Compare |
More CGEN Analysis
Data updated: May 03, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry